Re: PLURISTEM ADVANCES 2ND MAJOR CELL THERAPY LINE TO MANUF
in response to
by
posted on
Oct 21, 2014 09:15AM
Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place